| PDMR Dealing | 08-Dec-2025 | 15:15 | RNS |
| Holding(s) in Company | 08-Dec-2025 | 14:31 | RNS |
| Notification of major holdings | 08-Dec-2025 | 13:34 | RNS |
| Holding(s) in Company | 08-Dec-2025 | 12:48 | RNS |
| Directors' / PDMR dealing | 08-Dec-2025 | 12:18 | RNS |
| AGM Post-Meeting Shareholder Engagement Update | 08-Dec-2025 | 09:00 | RNS |
| Expanded NRDL Coverage + CIDL Inclusion in China | 08-Dec-2025 | 07:00 | RNS |
| Preliminary Data in Faridoxorubicin Phase 1b Trial | 08-Dec-2025 | 07:00 | RNS |
| Posting of Annual Report and AGM Notice | 08-Dec-2025 | 07:00 | RNS |
| Appointment of Francis Van Parys as CEO | 08-Dec-2025 | 07:00 | RNS |
| Substantial contract for Proteome Sciences | 08-Dec-2025 | 07:00 | RNS |
| Transaction in Own Shares | 08-Dec-2025 | 07:00 | RNS |
| Holding(s) in Company | 05-Dec-2025 | 10:56 | RNS |
| Transaction in Own Shares | 05-Dec-2025 | 07:00 | RNS |
| Final Results | 05-Dec-2025 | 07:00 | RNS |
| Price | 25,248.01 |
| Closing Price Change | 12.80 |
| % Change | 0.05 % |
| 08-Dec-25 Close | 25,248.01 |
You are here: research